aod9604 human clinical trials weight loss results AOD-9604 Trial & FDA Status (2026) AOD 9604 Peptide Guide: Dosing,
Description
Loader Please wait while your request is being verified...
AOD-9604 (Anti-Obesity Drug 9604) is a modified peptide fragment consisting of the terminal 15 amino acids of human growth hormone (positions 176-191) with a tyrosine residue added at the N-terminus for stability
(2010) Osteoarthritis and Cartilage Transgenic mouse model of accelerated OA treated with AOD 9604
(2013) Journal of Obesity & Weight Loss Therapy n=300 Small RCT testing AOD-9604 in overweight subjects
AOD-9604 Safety: What Do Clinical Trials Show
Both require fasted administration, so the timing is straightforward
